Title |
Melatonin and Nitrones As Potential Therapeutic Agents for Stroke
|
---|---|
Published in |
Frontiers in Aging Neuroscience, November 2016
|
DOI | 10.3389/fnagi.2016.00281 |
Pubmed ID | |
Authors |
Alejandro Romero, Eva Ramos, Paloma Patiño, Maria J. Oset-Gasque, Francisco López-Muñoz, José Marco-Contelles, María I. Ayuso, Alberto Alcázar |
Abstract |
Stroke is a disease of aging affecting millions of people worldwide, and recombinant tissue-type plasminogen activator (r-tPA) is the only treatment approved. However, r-tPA has a low therapeutic window and secondary effects which limit its beneficial outcome, urging thus the search for new more efficient therapies. Among them, neuroprotection based on melatonin or nitrones, as free radical traps, have arisen as drug candidates due to their strong antioxidant power. In this Perspective article, an update on the specific results of the melatonin and several new nitrones are presented. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Switzerland | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 6% |
Unknown | 16 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 3 | 18% |
Student > Doctoral Student | 2 | 12% |
Student > Master | 2 | 12% |
Researcher | 2 | 12% |
Student > Bachelor | 2 | 12% |
Other | 3 | 18% |
Unknown | 3 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 3 | 18% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 12% |
Agricultural and Biological Sciences | 2 | 12% |
Chemistry | 2 | 12% |
Sports and Recreations | 1 | 6% |
Other | 4 | 24% |
Unknown | 3 | 18% |